What is Universal Health Services, Inc.'s earnings per share (EPS)?

Universal Health Services, Inc. (UHS) reported diluted earnings per share of $23.10 for fiscal year 2025. This represents a 37.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Universal Health Services, Inc. (UHS) Financials

UHS

Trailing 12 months to June 30, 2026

Revenue $18.1B +10.0% YoY

Net Income $1.5B +21.0% YoY

EPS (Diluted) $24.52 +29.3% YoY

Free Cash Flow $845.4M -6.2% YoY

Market Cap $10.3B as of Sep 12, 2026

Price / Sales 0.6x on $18.1B revenue, trailing 12 months to June 30, 2026

Price / Earnings 6.8x on $1.5B net income, trailing 12 months to June 30, 2026

Price / Book 1.4x on $7.5B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 7, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the UHS SEC filings page.

Universal Health Services, Inc. (UHS) reported $18.1B in revenue over the twelve months to Jun 30, 2026, up 10.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI UHS FY2025 2026-08-29

Cash conversion has strengthened alongside deleveraging, while reinvestment and working-capital demands keep reported profit from fully becoming free cash flow.

Between FY2021 and FY2025, operating cash flow climbed from $884M to $1.9B, indicating that reported earnings became more cash-realized over the period. In FY2025, net income of $1.5B exceeded free cash flow of $849M, so capital reinvestment absorbed a meaningful portion of the cash produced.

Operating margin recovered from 7.5% in FY2022 to 11.5% in FY2025, making the recent profit improvement an operating-margin shift rather than simple top-line expansion. Debt-to-equity fell from 0.8x in FY2022 to 0.6x in FY2025, so that improvement coincided with lower balance-sheet dependence.

Current liquidity cushion narrowed as the current ratio moved from 1.4x in FY2023 to 1.1x in FY2025, despite stronger operating cash flow. FY2025 receivables of $2.6B and capital expenditures of $1.0B show cash being absorbed by working capital and reinvestment while shareholder distributions continued.

Financial Health Signals

Financial Health Score 54/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Universal Health Services, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Universal Health Services, Inc. has an operating margin of 11.5%, meaning the company retains $11 of operating profit per $100 of revenue. This strong profitability earns a score of 72/100, reflecting efficient cost management and pricing power. This is up from 10.6% the prior year.

Growth

Universal Health Services, Inc.'s revenue grew 9.7% year-over-year to $17.4B, a solid pace of expansion. This earns a growth score of 66/100.

Leverage

Universal Health Services, Inc. has a moderate D/E ratio of 0.55. This balance of debt and equity financing earns a leverage score of 38/100.

Liquidity

Universal Health Services, Inc.'s current ratio of 1.05 is below the typical benchmark, resulting in a score of 21/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Universal Health Services, Inc. has a free cash flow margin of 4.9%, earning a moderate score of 46/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Universal Health Services, Inc. earns a strong 20.5% return on equity (ROE), meaning it generates $20 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 79/100. This is up from 17.1% the prior year.

Altman Z-Score Safe

3.02

Universal Health Services, Inc. scores 3.02, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/7

Universal Health Services, Inc. passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.25x

For every $1 of reported earnings, Universal Health Services, Inc. generates $1.25 in operating cash flow ($1.9B OCF vs $1.5B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

12.78x

Universal Health Services, Inc. earns $12.78 in operating income for every $1 of interest expense ($2.0B vs $156.1M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.6B

YoY+8.3%

QoQ+3.2%

5Y CAGR+7.7%

10Y CAGR+6.7%

Universal Health Services, Inc. generated $4.6B in revenue in Q2 2026. This represents an increase of 8.3% from the same quarter a year earlier. Against the prior quarter it is up 3.2%.

EBITDA

$684.0M

YoY+4.9%

QoQ+3.9%

5Y CAGR+3.6%

Universal Health Services, Inc.'s EBITDA was $684.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.9% from the same quarter a year earlier. Against the prior quarter it is up 3.9%.

Net Income

$358.4M

YoY+1.5%

QoQ+2.8%

5Y CAGR+2.0%

10Y CAGR+6.8%

Universal Health Services, Inc. reported $358.4M in net income in Q2 2026. This represents an increase of 1.5% from the same quarter a year earlier. Against the prior quarter it is up 2.8%.

EPS (Diluted)

$5.98

YoY+10.1%

QoQ+5.8%

5Y CAGR+9.6%

10Y CAGR+12.2%

Universal Health Services, Inc. earned $5.98 per diluted share (EPS) in Q2 2026. This represents an increase of 10.1% from the same quarter a year earlier. Against the prior quarter it is up 5.8%.

Cash & Balance Sheet

Free Cash Flow

$215.7M

YoY-23.8%

QoQ+16.9%

10Y CAGR-1.1%

Universal Health Services, Inc. generated $215.7M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 23.8% from the same quarter a year earlier. Against the prior quarter it is up 16.9%.

Cash & Debt

$138.8M

YoY+0.9%

QoQ+16.6%

5Y CAGR-7.0%

10Y CAGR+9.4%

Universal Health Services, Inc. held $138.8M in cash against $4.1B in long-term debt as of Q2 2026.

Dividends Per Share

$0.20

YoY0.0%

QoQ0.0%

5Y CAGR0.0%

Universal Health Services, Inc. paid $0.20 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

Diluted avg 60M

Universal Health Services, Inc. had a weighted average of 60M diluted shares in Q2 2026; the shares outstanding count is not reported for that period.

Margins & Returns

Operating Margin

11.1%

YoY-0.5pp

QoQ-0.1pp

5Y change-2.6pp

Universal Health Services, Inc.'s operating margin was 11.1% in Q2 2026, reflecting core business profitability. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Net Margin

7.7%

YoY-0.5pp

QoQ0.0pp

5Y change-2.4pp

10Y change+0.1pp

Universal Health Services, Inc.'s net profit margin was 7.7% in Q2 2026, showing the share of revenue converted to profit. This is down 0.5 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.

Return on Equity

4.8%

YoY-0.3pp

QoQ+0.1pp

5Y change-0.3pp

10Y change+0.5pp

Universal Health Services, Inc.'s ROE was 4.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Gross Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$320.8M

YoY+106.7%

QoQ+95.8%

5Y CAGR-2.3%

10Y CAGR+16.8%

Universal Health Services, Inc. spent $320.8M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 106.7% from the same quarter a year earlier. Against the prior quarter it is up 95.8%.

Capital Expenditures

$227.6M

YoY-14.4%

QoQ+4.8%

5Y CAGR-0.6%

10Y CAGR+6.6%

Universal Health Services, Inc. invested $227.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 14.4% from the same quarter a year earlier. Against the prior quarter it is up 4.8%.

R&D Spending

Not reported for Q2 2026.

UHS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UHS quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$18.1B	$17.4B+9.7%	$15.8B+10.8%	$14.3B+6.6%	$13.4B+6.0%	$12.6B+9.4%	$11.6B+1.6%	$11.4B+5.6%	$10.8B+3.5%	$10.4B+6.6%	$9.8B+8.0%	$9.0B+10.2%	$8.2B+11.4%	$7.4B+5.8%	$7.0B+3.0%	$6.8B
SG&A Expenses	$8.3B	$8.1B+7.5%	$7.5B+5.8%	$7.1B+5.1%	$6.8B+9.7%	$6.2B+9.8%	$5.6B+0.4%	$5.6B+6.4%	$5.3B+5.5%	$5.0B+8.6%	$4.6B+8.9%	$4.2B+9.5%	$3.8B+6.7%	$3.6B+4.8%	$3.4B+3.4%	$3.3B
Operating Income	$2.1B	$2.0B+18.6%	$1.7B+43.1%	$1.2B+17.1%	$1.0B-26.4%	$1.4B+0.3%	$1.4B+11.7%	$1.2B+3.5%	$1.2B-8.2%	$1.3B-0.1%	$1.3B+1.7%	$1.3B+18.4%	$1.1B+4.7%	$1.0B+7.7%	$942.6M+5.1%	$897.1M
EBITDA	N/A	$2.6B+15.3%	$2.3B+30.0%	$1.7B+10.0%	$1.6B-16.4%	$1.9B+1.5%	$1.9B+9.5%	$1.7B+4.8%	$1.6B-5.8%	$1.7B+1.8%	$1.7B+2.4%	$1.7B+15.2%	$1.4B+6.4%	$1.4B+8.1%	$1.3B+4.9%	$1.2B
Interest Expense	$157.7M	$156.1M-16.1%	$186.1M-10.0%	$206.7M+62.9%	$126.9M+51.7%	$83.7M-21.3%	$106.3M-34.7%	$162.7M+5.0%	$155.0M+6.7%	$145.2M+16.1%	$125.1M+10.2%	$113.5M-15.1%	$133.6M-8.5%	$146.1M-18.3%	$178.9M-10.9%	$200.8M
Income Tax	$476.4M	$461.0M+37.7%	$334.8M+51.4%	$221.1M+5.7%	$209.3M-31.5%	$305.7M+2.1%	$299.3M+25.3%	$238.8M+0.9%	$236.6M-34.9%	$363.7M-11.1%	$409.2M+3.5%	$395.2M+21.7%	$324.7M+3.0%	$315.3M+14.8%	$274.6M+11.0%	$247.5M
Net Income	$1.5B	$1.5B+30.4%	$1.1B+59.1%	$717.8M+6.2%	$675.6M-31.9%	$991.6M+5.0%	$944.0M+15.8%	$814.9M+4.5%	$779.7M+3.6%	$752.3M+7.1%	$702.4M+3.2%	$680.5M+24.8%	$545.3M+6.8%	$510.7M+15.2%	$443.4M+11.4%	$398.2M
EPS (Basic)	N/A	$23.42+36.5%	$17.16+65.8%	$10.35+12.1%	$9.23-23.0%	$11.99+8.4%	$11.06+20.7%	$9.16+9.7%	$8.35+6.2%	$7.86+8.9%	$7.22+4.8%	$6.89+24.8%	$5.52+6.0%	$5.21+14.0%	$4.57+11.7%	$4.09
EPS (Diluted)	$24.52	$23.10+37.3%	$16.82+64.4%	$10.23+11.9%	$9.14-22.7%	$11.82+7.6%	$10.99+20.4%	$9.13+9.9%	$8.31+6.4%	$7.81+9.4%	$7.14+5.6%	$6.76+24.7%	$5.42+5.4%	$5.14+13.5%	$4.53+12.1%	$4.04
Diluted Shares (Avg)	N/A	64M-5.1%	68M-3.2%	70M-5.0%	74M-11.8%	84M-2.2%	86M-3.9%	89M-5.0%	94M-2.7%	96M-2.1%	98M-2.3%	101M+0.1%	101M+1.2%	99M+1.7%	98M-0.8%	99M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$4.6B+8.3%	$4.5B+9.6%	$4.5B+9.1%	$4.5B+13.4%	$4.3B+9.6%	$4.1B+6.7%	$4.1B+11.1%	$4.0B+11.2%
SG&A Expenses	$2.1B+6.2%	$2.1B+7.0%	$2.0B+7.3%	$2.1B+8.3%	$2.0B+8.5%	$2.0B+5.9%	$1.9B+6.0%	$1.9B+7.1%
Operating Income	$516.7M+3.3%	$502.9M+10.6%	$517.2M+9.5%	$521.7M+35.8%	$500.3M+14.6%	$454.8M+17.0%	$472.5M+42.7%	$384.2M+34.6%
EBITDA	$684.0M+4.9%	$658.3M+9.1%	$680.6M+9.9%	$676.7M+26.8%	$652.3M+11.7%	$603.2M+13.9%	$619.3M+29.9%	$533.7M+26.3%
Interest Expense	$39.9M+12.9%	$37.1M-7.3%	$42.2M+6.3%	$38.4M-13.9%	$35.4M-27.7%	$40.1M-24.2%	$39.7M-25.9%	$44.7M-16.3%
Income Tax	$114.5M+3.4%	$110.4M+11.8%	$133.6M+31.9%	$117.8M+55.7%	$110.8M+26.3%	$98.8M+40.6%	$101.3M+64.7%	$75.6M+44.0%
Net Income	$358.4M+1.5%	$348.7M+10.1%	$445.9M+34.2%	$373.0M+44.2%	$353.2M+22.2%	$316.7M+20.9%	$332.4M+53.6%	$258.7M+54.9%
EPS (Basic)	$6.01+9.5%	$5.71+17.2%	$7.15+41.6%	$5.92+52.2%	$5.49+27.1%	$4.87+24.9%	$5.05+59.3%	$3.89+60.7%
EPS (Diluted)	$5.98+10.1%	$5.65+17.7%	$7.03+42.3%	$5.86+54.2%	$5.43+27.5%	$4.80+25.7%	$4.94+57.3%	$3.80+58.3%
Diluted Shares (Avg)	60M-7.8%	62M-6.6%	N/A	64M-6.5%	65M-4.3%	66M-3.6%	N/A	68M-2.2%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

UHS Balance Sheet

UHS quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$15.5B+7.3%	$14.5B+3.6%	$14.0B+3.5%	$13.5B+3.1%	$13.1B-2.8%	$13.5B+15.5%	$11.7B+3.6%	$11.3B+4.7%	$10.8B+4.3%	$10.3B+7.3%	$9.6B+7.4%	$9.0B+7.7%	$8.3B+1.4%	$8.2B+7.0%	$7.7B
Current Assets	$3.4B+21.0%	$2.8B+0.2%	$2.8B+10.8%	$2.5B+12.1%	$2.3B-31.0%	$3.3B+71.3%	$1.9B-1.1%	$1.9B+7.8%	$1.8B+6.9%	$1.7B-2.1%	$1.7B+6.4%	$1.6B+12.8%	$1.4B+1.8%	$1.4B+3.1%	$1.4B
Cash & Equivalents	$137.8M+9.4%	$126.0M+5.5%	$119.4M+16.2%	$102.8M-10.8%	$115.3M-90.6%	$1.2B+1898.6%	$61.3M-41.8%	$105.2M+41.4%	$74.4M+120.5%	$33.7M-44.9%	$61.2M+90.9%	$32.1M+86.0%	$17.2M-26.6%	$23.5M-43.1%	$41.2M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$2.6B+19.5%	$2.2B-2.7%	$2.2B+10.9%	$2.0B+15.5%	$1.7B+1.0%	$1.7B+10.8%	$1.6B+3.4%	$1.5B+0.6%	$1.5B+4.3%	$1.4B+10.5%	$1.3B+1.5%	$1.3B+14.8%	$1.1B+4.7%	$1.1B+10.0%	$969.8M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.0B+1.5%	$3.9B0.0%	$3.9B+0.6%	$3.9B-1.3%	$4.0B+2.1%	$3.9B+0.3%	$3.9B+0.7%	$3.8B+0.5%	$3.8B+1.1%	$3.8B+5.2%	$3.6B+9.3%	$3.3B+7.9%	$3.0B+0.4%	$3.0B+15.6%	$2.6B
Total Liabilities	$8.3B+5.7%	$7.8B-0.2%	$7.8B+3.2%	$7.6B+8.1%	$7.0B-2.2%	$7.2B+16.2%	$6.2B+4.9%	$5.9B+1.8%	$5.8B-0.2%	$5.8B+7.8%	$5.4B+2.9%	$5.2B+3.0%	$5.1B-7.8%	$5.5B+2.2%	$5.4B
Current Liabilities	$3.2B+46.6%	$2.2B+9.8%	$2.0B+5.2%	$1.9B-3.5%	$2.0B-20.0%	$2.5B+58.7%	$1.6B+7.9%	$1.4B-21.6%	$1.8B+40.3%	$1.3B+19.7%	$1.1B-7.0%	$1.2B+11.6%	$1.1B+18.5%	$894.1M+6.8%	$836.9M
Non-Current Liabilities	$5.0B-10.4%	$5.6B-3.7%	$5.8B+2.6%	$5.7B+12.7%	$5.0B+7.3%	$4.7B+1.7%	$4.6B+3.9%	$4.4B+12.8%	$3.9B-12.2%	$4.5B+4.7%	$4.3B+5.8%	$4.0B+0.8%	$4.0B-12.9%	$4.6B+1.4%	$4.5B
Long-Term Debt	$4.0B-10.3%	$4.5B-6.7%	$4.8B+1.3%	$4.7B+14.1%	$4.1B+17.5%	$3.5B-9.6%	$3.9B-1.0%	$3.9B+12.6%	$3.5B-13.3%	$4.0B+19.6%	$3.4B+4.9%	$3.2B0.0%	$3.2B-13.9%	$3.7B+2.1%	$3.7B
Total Equity	$7.3B+9.1%	$6.7B+8.4%	$6.1B+3.9%	$5.9B-2.8%	$6.1B-3.6%	$6.3B+14.8%	$5.5B+2.1%	$5.4B+8.0%	$5.0B+10.1%	$4.5B+6.7%	$4.2B+13.8%	$3.7B+15.0%	$3.2B+19.8%	$2.7B+18.2%	$2.3B
Retained Earnings	$8.0B+8.4%	$7.4B+8.4%	$6.8B+4.1%	$6.5B-1.1%	$6.6B-2.1%	$6.7B+13.7%	$5.9B+2.4%	$5.8B+8.2%	$5.4B+9.4%	$4.9B+7.1%	$4.6B+13.7%	$4.0B+14.7%	$3.5B+18.1%	$3.0B+18.8%	$2.5B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$15.9B+6.3%	$15.7B+5.4%	$15.5B+7.3%	$15.3B+6.9%	$15.0B+6.5%	$14.9B+5.9%	$14.5B+3.6%	$14.4B+3.5%
Current Assets	$3.7B+23.1%	$3.5B+13.7%	$3.4B+21.0%	$3.3B+16.3%	$3.0B+9.1%	$3.1B+7.2%	$2.8B+0.2%	$2.8B+1.8%
Cash & Equivalents	$138.8M+0.9%	$119.0M-6.1%	$137.8M+9.4%	$112.9M+6.4%	$137.6M+6.8%	$126.8M+13.1%	$126.0M+5.5%	$106.1M+31.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$2.8B+21.7%	$2.7B+13.8%	$2.6B+19.5%	$2.6B+16.8%	$2.3B+6.7%	$2.4B+4.9%	$2.2B-2.7%	$2.2B-0.9%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.0B+0.1%	$4.0B+0.8%	$4.0B+1.5%	$4.0B+0.6%	$4.0B+0.9%	$3.9B+0.5%	$3.9B0.0%	$4.0B+1.4%
Total Liabilities	$8.4B+5.9%	$8.2B+1.6%	$8.3B+5.7%	$8.2B+5.5%	$8.0B+4.9%	$8.1B+3.9%	$7.8B-0.2%	$7.7B-0.8%
Current Liabilities	$3.3B+42.3%	$3.2B+39.2%	$3.2B+46.6%	$3.2B+57.1%	$2.3B+7.8%	$2.3B+12.3%	$2.2B+9.8%	$2.0B+1.1%
Non-Current Liabilities	$5.1B-9.1%	$5.0B-13.7%	$5.0B-10.4%	$5.0B-12.6%	$5.6B+3.7%	$5.8B+0.8%	$5.6B-3.7%	$5.7B-1.4%
Long-Term Debt	$4.1B-10.2%	$4.0B-14.3%	$4.0B-10.3%	$4.0B-14.4%	$4.5B+2.8%	$4.6B-2.6%	$4.5B-6.7%	$4.6B-3.7%
Total Equity	$7.5B+6.9%	$7.5B+10.0%	$7.3B+9.1%	$7.2B+8.5%	$7.0B+8.4%	$6.8B+8.5%	$6.7B+8.4%	$6.6B+8.9%
Retained Earnings	N/A	N/A	$8.0B+8.4%	N/A	N/A	N/A	$7.4B+8.4%	N/A

Not reported in any period shown, so not listed: Inventory.

UHS Cash Flow Statement

UHS quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.8B	$1.9B-9.8%	$2.1B+63.0%	$1.3B+27.3%	$996.0M+12.7%	$883.7M-62.6%	$2.4B+64.1%	$1.4B+12.8%	$1.3B+2.2%	$1.2B-6.5%	$1.3B+24.9%	$1.1B+3.1%	$1.0B+17.1%	$884.2M+10.6%	$799.2M+12.5%	$710.7M
Depreciation & Amortization	N/A	$618.7M+5.8%	$584.8M+3.0%	$568.0M-2.4%	$581.9M+9.1%	$533.2M+4.5%	$510.5M+4.1%	$490.4M+8.2%	$453.0M+1.2%	$447.8M+7.5%	$416.6M+4.5%	$398.6M+6.1%	$375.6M+11.3%	$337.4M+9.3%	$308.7M+4.3%	$295.9M
Stock-Based Compensation	N/A	$95.7M-3.7%	$99.3M+13.3%	$87.7M+2.7%	$85.4M+15.9%	$73.7M+11.9%	$65.8M-5.2%	$69.4M+4.3%	$66.6M+17.3%	$56.7M+17.9%	$48.1M+20.4%	$40.0M+28.6%	$31.1M+11.9%	$27.8M+23.4%	$22.5M+23.6%	$18.2M
Capital Expenditures	$954.9M	$1.0B+7.6%	$943.8M+27.0%	$743.1M+1.2%	$734.0M-14.2%	$855.7M+17.0%	$731.3M+15.3%	$634.1M-4.6%	$665.0M+19.3%	$557.5M+7.2%	$519.9M+37.1%	$379.3M-3.0%	$391.1M+9.1%	$358.5M-1.3%	$363.2M+27.1%	$285.7M
Free Cash Flow	$845.4M	$849.2M-24.4%	$1.1B+114.1%	$524.7M+100.3%	$262.0M+834.6%	$28.0M-98.3%	$1.6B+102.5%	$804.4M+31.9%	$609.8M-11.6%	$690.1M-15.2%	$813.9M+18.1%	$688.9M+6.9%	$644.7M+22.6%	$525.7M+20.6%	$436.0M+2.6%	$425.0M
Investing Cash Flow	-$925.2M	-$1.1B-17.5%	-$911.1M-19.4%	-$763.3M-17.9%	-$647.3M+29.2%	-$914.5M-13.9%	-$802.6M-16.6%	-$688.4M+7.9%	-$747.2M-9.1%	-$684.7M+40.7%	-$1.2B-26.5%	-$912.9M-9.6%	-$832.8M-117.2%	-$383.5M+51.4%	-$789.6M-176.3%	-$285.8M
Financing Cash Flow	-$842.0M	-$749.7M+34.5%	-$1.1B-131.8%	-$493.9M-55.1%	-$318.4M+70.2%	-$1.1B-177.8%	-$384.9M+54.5%	-$845.0M-71.7%	-$492.2M+5.2%	-$519.2M-203.3%	-$171.2M-37.4%	-$124.6M+33.5%	-$187.4M+63.0%	-$507.0M-1750.5%	-$27.4M+93.4%	-$413.1M
Dividends Paid	$49.9M	$51.3M-3.9%	$53.3M-3.8%	$55.5M-5.1%	$58.4M-11.3%	$65.9M+279.9%	$17.3M-67.3%	$53.0M+41.9%	$37.3M-2.3%	$38.2M-1.7%	$38.9M-1.7%	$39.5M+33.3%	$29.7M+51.2%	$19.6M-66.4%	$58.4M+200.0%	$19.5M
Share Buybacks	$1.1B	$968.0M+44.3%	$670.8M+22.5%	$547.4M-34.3%	$832.9M-31.8%	$1.2B+490.6%	$206.7M-73.2%	$770.5M+93.9%	$397.4M+9.1%	$364.4M+3.1%	$353.4M+68.5%	$209.8M+108.2%	$100.7M+270.4%	$27.2M+42.0%	$19.2M-68.3%	$60.5M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$443.3M-19.2%	$401.6M+11.5%	$574.7M-12.7%	$380.7M+14.3%	$549.0M-19.2%	$360.0M-9.2%	$658.4M+45.5%	$333.0M+106.0%
Depreciation & Amortization	$167.3M+10.1%	$155.4M+4.8%	$163.3M+11.3%	$155.1M+3.7%	$152.0M+3.1%	$148.3M+5.2%	$146.8M+0.9%	$149.6M+9.0%
Stock-Based Compensation	N/A	$22.5M+4.2%	N/A	N/A	N/A	$21.6M+10.0%	N/A	N/A
Capital Expenditures	$227.6M-14.4%	$217.2M-9.1%	$281.2M+14.3%	$228.9M-7.7%	$266.0M+10.2%	$239.0M+14.6%	$245.9M+19.2%	$247.9M+24.0%
Free Cash Flow	$215.7M-23.8%	$184.5M+52.4%	$293.5M-28.9%	$151.8M+78.5%	$283.0M-35.4%	$121.0M-35.6%	$412.5M+67.7%	$85.0M+321.8%
Investing Cash Flow	-$234.2M+23.4%	-$197.6M+27.2%	-$224.0M-7.7%	-$269.4M-1.4%	-$305.9M-26.0%	-$271.3M-39.4%	-$208.0M+12.9%	-$265.6M-50.6%
Financing Cash Flow	-$189.5M+16.8%	-$221.9M-142.7%	-$296.1M+30.6%	-$134.5M-50.1%	-$227.7M+45.7%	-$91.4M+56.2%	-$426.8M-134.1%	-$89.7M-598.9%
Dividends Paid	$11.9M-9.2%	$13.0M-4.1%	$12.4M-5.2%	$12.7M-5.8%	$13.1M-3.4%	$13.5M-0.5%	$13.0M-3.5%	$13.5M-2.4%
Share Buybacks	$320.8M+106.7%	$163.8M-26.7%	$352.0M+40.7%	$237.4M+30.0%	$155.2M+61.8%	$223.4M+57.2%	$250.2M+54.4%	$182.6M+4.0%

UHS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UHS quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	11.5%+0.8pp	10.6%+2.4pp	8.2%+0.7pp	7.5%-3.3pp	10.8%-1.0pp	11.8%+1.1pp	10.7%-0.2pp	10.9%-1.4pp	12.3%-0.8pp	13.1%-0.8pp	13.9%+1.0pp	13.0%-0.8pp	13.8%+0.2pp	13.5%+0.3pp	13.3%
Net Margin	8.6%+1.3pp	7.2%+2.2pp	5.0%0.0pp	5.0%-2.8pp	7.8%-0.3pp	8.2%+1.0pp	7.2%-0.1pp	7.2%0.0pp	7.2%0.0pp	7.2%-0.3pp	7.5%+0.9pp	6.7%-0.3pp	6.9%+0.6pp	6.4%+0.5pp	5.9%
Return on Equity	20.5%+3.3pp	17.1%+5.5pp	11.7%+0.3pp	11.4%-4.9pp	16.3%+1.3pp	14.9%+0.1pp	14.8%+0.3pp	14.5%-0.6pp	15.1%-0.4pp	15.5%-0.5pp	16.0%+1.4pp	14.6%-1.1pp	15.7%-0.6pp	16.3%-1.0pp	17.3%
Return on Assets	9.6%+1.7pp	7.9%+2.7pp	5.1%+0.1pp	5.0%-2.6pp	7.6%+0.6pp	7.0%0.0pp	7.0%+0.1pp	6.9%-0.1pp	7.0%+0.2pp	6.8%-0.3pp	7.1%+1.0pp	6.1%-0.1pp	6.1%+0.7pp	5.4%+0.2pp	5.2%
Current Ratio	1.05-0.2x	1.27-0.1x	1.40+0.1x	1.33+0.2x	1.14-0.2x	1.32+0.1x	1.23-0.1x	1.34+0.4x	0.97-0.3x	1.28-0.3x	1.56+0.2x	1.370.0x	1.35-0.2x	1.57-0.1x	1.63
Debt-to-Equity	0.55-0.1x	0.67-0.1x	0.780.0x	0.80+0.1x	0.68+0.1x	0.56-0.2x	0.710.0x	0.730.0x	0.70-0.2x	0.89+0.1x	0.79-0.1x	0.86-0.1x	0.99-0.4x	1.37-0.2x	1.59
Asset Turnover	1.120.0x	1.09+0.1x	1.020.0x	0.990.0x	0.97+0.1x	0.86-0.1x	0.980.0x	0.960.0x	0.970.0x	0.950.0x	0.940.0x	0.920.0x	0.890.0x	0.850.0x	0.88
FCF Margin	4.9%-2.2pp	7.1%+3.4pp	3.7%+1.7pp	2.0%+1.7pp	0.2%-13.9pp	14.1%+7.0pp	7.1%+1.4pp	5.7%-1.0pp	6.6%-1.7pp	8.3%+0.7pp	7.6%-0.2pp	7.9%+0.7pp	7.1%+0.9pp	6.3%0.0pp	6.3%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Margin	11.1%-0.5pp	11.2%+0.1pp	11.5%0.0pp	11.6%+1.9pp	11.7%+0.5pp	11.1%+1.0pp	11.5%+2.6pp	9.7%+1.7pp
Net Margin	7.7%-0.5pp	7.8%0.0pp	9.9%+1.9pp	8.3%+1.8pp	8.3%+0.9pp	7.7%+0.9pp	8.1%+2.2pp	6.5%+1.8pp
Return on Equity	4.8%-0.3pp	4.7%0.0pp	6.1%+1.1pp	5.2%+1.3pp	5.0%+0.6pp	4.7%+0.5pp	5.0%+1.5pp	3.9%+1.2pp
Return on Assets	2.3%-0.1pp	2.2%+0.1pp	2.9%+0.6pp	2.4%+0.6pp	2.4%+0.3pp	2.1%+0.3pp	2.3%+0.8pp	1.8%+0.6pp
Current Ratio	1.12-0.2x	1.08-0.2x	1.05-0.2x	1.03-0.4x	1.290.0x	1.32-0.1x	1.27-0.1x	1.390.0x
Debt-to-Equity	0.54-0.1x	0.53-0.1x	0.55-0.1x	0.55-0.1x	0.650.0x	0.68-0.1x	0.67-0.1x	0.70-0.1x
Asset Turnover	0.290.0x	0.290.0x	0.290.0x	0.290.0x	0.290.0x	0.280.0x	0.280.0x	0.280.0x
FCF Margin	4.7%-2.0pp	4.1%+1.2pp	6.5%-3.5pp	3.4%+1.2pp	6.6%-4.6pp	2.9%-1.9pp	10.0%+3.4pp	2.1%+3.2pp

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Universal Health Services, Inc. UHS	FY2025	$17.4B	$1.5B	8.6%	$10.3B	54/100
Encompass Health Corporation EHC	FY2025	$5.9B	$566.2M	9.5%	$12.0B	32/100
Tenet Healthcare Corporation New THC	FY2025	$21.3B	$2.4B	11.1%	$21.2B	56/100
Fresenius Medical Care AG FMS	FY2016	$17.9B	$1.2B	6.9%	$11.9B	—
The Ensign Group, Inc. ENSG	FY2025	$5.1B	$344.0M	6.8%	$10.1B	59/100
HCA Healthcare, Inc. HCA	FY2025	$75.6B	$6.8B	9.0%	$92.4B	23/100

Where Universal Health Services, Inc. Ranks

Frequently Asked Questions

What is Universal Health Services, Inc.'s annual revenue?

Universal Health Services, Inc. (UHS) reported $17.4B in total revenue for fiscal year 2025. This represents a 9.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Universal Health Services, Inc.'s revenue growing?

Universal Health Services, Inc. (UHS) revenue grew by 9.7% year-over-year, from $15.8B to $17.4B in fiscal year 2025.

Is Universal Health Services, Inc. profitable?

Yes, Universal Health Services, Inc. (UHS) reported a net income of $1.5B in fiscal year 2025, with a net profit margin of 8.6%.

What is Universal Health Services, Inc.'s EBITDA?

Universal Health Services, Inc. (UHS) had EBITDA of $2.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Universal Health Services, Inc. have?

As of fiscal year 2025, Universal Health Services, Inc. (UHS) had $137.8M in cash and equivalents against $4.0B in long-term debt.

What is Universal Health Services, Inc.'s operating margin?

Universal Health Services, Inc. (UHS) had an operating margin of 11.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Universal Health Services, Inc.'s net profit margin?

Universal Health Services, Inc. (UHS) had a net profit margin of 8.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Universal Health Services, Inc. pay dividends?

Yes, Universal Health Services, Inc. (UHS) paid $0.80 per share in dividends during fiscal year 2025.

What is Universal Health Services, Inc.'s return on equity (ROE)?

Universal Health Services, Inc. (UHS) has a return on equity of 20.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Universal Health Services, Inc.'s free cash flow?

Universal Health Services, Inc. (UHS) generated $849.2M in free cash flow during fiscal year 2025. This represents a -24.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Universal Health Services, Inc.'s operating cash flow?

Universal Health Services, Inc. (UHS) generated $1.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Universal Health Services, Inc.'s total assets?

Universal Health Services, Inc. (UHS) had $15.5B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Universal Health Services, Inc.'s capital expenditures?

Universal Health Services, Inc. (UHS) invested $1.0B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Universal Health Services, Inc. buy back shares?

Yes, Universal Health Services, Inc. (UHS) spent $968.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

What is Universal Health Services, Inc.'s current ratio?

Universal Health Services, Inc. (UHS) had a current ratio of 1.05 as of fiscal year 2025, which is considered adequate.

What is Universal Health Services, Inc.'s debt-to-equity ratio?

Universal Health Services, Inc. (UHS) had a debt-to-equity ratio of 0.55 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Universal Health Services, Inc.'s return on assets (ROA)?

Universal Health Services, Inc. (UHS) had a return on assets of 9.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Universal Health Services, Inc.'s P/E ratio?

Universal Health Services, Inc. (UHS) trades at 6.8x earnings, its market capitalization divided by net income of $1.5B net income, trailing 12 months to June 30, 2026. The market capitalization is $10.3B as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Universal Health Services, Inc.'s price-to-sales ratio?

Universal Health Services, Inc. (UHS) trades at 0.6x sales, its market capitalization divided by revenue of $18.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $10.3B as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Universal Health Services, Inc.'s Altman Z-Score?

Universal Health Services, Inc. (UHS) has an Altman Z-Score of 3.02, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Universal Health Services, Inc.'s Piotroski F-Score?

Universal Health Services, Inc. (UHS) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Universal Health Services, Inc.'s earnings high quality?

Universal Health Services, Inc. (UHS) has an earnings quality ratio of 1.25x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Universal Health Services, Inc. cover its interest payments?

Universal Health Services, Inc. (UHS) has an interest coverage ratio of 12.78x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Universal Health Services, Inc.?

Universal Health Services, Inc. (UHS) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.